Anti-Cytochrome P450 2E1 [M12P4H2]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 152160 |
| Applications | IHC WB |
| Antigen/Gene or Protein Targets | Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1) |
| Reactivity | Human |
| Relevance | Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms. |
| Host | Mouse |
| Immunogen | Ovalbumin-conjugated synthetic peptide HIGFGCIPPR (C-terminal sequence) |
| Positive Control | IHC: formalin-fixed, paraffin-embedded human liver sections; WB: pooled human liver microsomes |
| Subclass | IgG1 lambda |
| Myeloma Used | P3X63Ag8.653 |
| Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine). |
| Strain | Balb/c |
| Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference